Skip to main content
. 2022 Oct 11;11(10):1392. doi: 10.3390/antibiotics11101392

Table 3.

AD Compared with rBMD and BMAD for polymyxin B and colistin.

Species Tested Agents rBMD* BMAD
% VME ME CA EA VME ME CA EA
E. coli PMB 2.5 0 97.5 80 0 0 100 87.5
K. pneumoniae 10.5 0 89.5 94.7 5.3 0 94.7 89.5
E. cloacae 10.8 0 89.2 86.5 0 0 100 62.2
K. aerogenes 3.3 0 96.7 90 0 0 100 73.3
A. baumannii 15.8 0 84.2 76.3 2.6 0 97.4 86.8
P. aeruginosa 29.7 2.7 67.6 81.1 0 2.7 97.3 73
Total (%) 12.2 0.4 87.3 85 1.4 0.4 98.2 79.1
E. coli CST 2.5 0 97.5 67.5 0 0 100 92.5
K. pneumoniae 7.9 0 92.1 68.4 2.6 0 97.4 86.8
E. cloacae 0 0 100 78.4 2.7 0 97.3 89.2
K. aerogenes 0 0 100 73.3 6.7 0 93.3 90
A. baumannii 7.9 0 92.1 71.1 0 0 100 100
P. aeruginosa 35.1 0 64.9 94.6 10.8 0 89.2 89.2
Total (%) 9.1 0 90.9 75.1 3.6 0 96.4 91.8

VME: very major errors; ME: major errors; CA: categorical agreement; EA: essential agreement; PMB: polymyxin B; CST: colistin; BMAD: broth macrodilution; AD: agar dilution; rBMD: reference broth microdilution. *: using tissue-culture-treated microtiter plates.